Actipulse Neuroscience Announces Successful Clinical Trial Using Fast Gamma Magnetic Stimulation for the Treatment of Alzheimer's Disease
September 30, 2021 15:00 ET
|
Actipulse Neuroscience
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Today, the results of a recent pilot clinical trial, funded by neurotech company Actipulse Neuroscience, have demonstrated that its non-invasive...
PathMaker Neurosystems Announces Completion of Pivotal European Clinical Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
September 27, 2021 05:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 27, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
PathMaker Neurosystems Announces Receipt of NIH Grant For Application of its Non-Invasive Neuromodulation Technology to Amyotrophic Lateral Sclerosis (ALS)
September 20, 2021 13:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 20, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Worldwide Neuromodulation Industry to 2027 - Strong Product Pipeline With Various Innovations Presents Opportunities
September 01, 2021 04:13 ET
|
Research and Markets
Dublin, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The "Neuromodulation Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's...
Integer to Exhibit at 2021 MD&M West Expo, Aug. 10-12
August 09, 2021 12:00 ET
|
Integer Holdings Corporation
PLANO, Texas, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech industry leaders and innovators...
Groundbreaking Study Establishes Non-Surgical Treatment Modality to Improve Function in Children With Cerebral Palsy
July 13, 2021 12:00 ET
|
SpineX
LOS ANGELES, July 13, 2021 (GLOBE NEWSWIRE) -- SpineX, Inc., today announced the publication of new data in the esteemed medical journal, Neurotherapeutics which supports the implementation of their...
Global Mental Health Care Market Research Report 2020: Emerging Neuromodulation Technologies Enabling Growth Opportunities
May 27, 2021 05:43 ET
|
Research and Markets
Dublin, May 27, 2021 (GLOBE NEWSWIRE) -- The "Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care" report has been added to ResearchAndMarkets.com's offering. ...
Nexstim Abp lämnar uppmuntrande resultat från den första pilotstudien i svår depression vid Kuopio universitetssjukhus
March 03, 2021 02:00 ET
|
Nexstim Oyj
Företagsmeddelande, insiderinformation, Helsingfors, 3 mars 2021 kl. 9.00 (EET) Nexstim Abp lämnar uppmuntrande resultat från den första pilotstudien i svår depression vid Kuopio...
Nexstim Oyj esittää rohkaisevat tulokset Kuopion yliopistollisen sairaalaan vakavan masennuksen hoidon alustavasta pilottitutkimuksesta
March 03, 2021 02:00 ET
|
Nexstim Oyj
Yhtiötiedote, sisäpiiritieto, Helsinki, 3.3.2021 klo 9.00 (EET) Nexstim Oyj esittää rohkaisevat tulokset Kuopion yliopistollisen sairaalaan vakavan masennuksen hoidon alustavasta...
Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University Hospital
March 03, 2021 02:00 ET
|
Nexstim Oyj
Company announcement, Inside information, Helsinki, 3 March 2021 at 9.00 am (EET) Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University...